THE CHOLANGIOCARCINOMA FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$5,767,836
Cash & Equivalents
43%
Investments
29%
Receivables (Non-Related)
21%
Prepaid Expenses
5%
Property, Plant, & Equipment (net)
1%
Inventories
<1%
Related-Party Receivables
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$1,220,153
Grants Payable
44%
Payables & Accruals
35%
Deferred Revenue
21%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$3,835,181
$2,500,678
-35%
Receivables (Non-Related)
$464,325
$1,235,312
+166%
Related-Party Receivables
-
-
-
Inventories
$88,631
$32,654
-63%
Prepaid Expenses
$239,926
$264,817
+10%
Investments
$1,260,098
$1,671,892
+33%
Property, Plant, & Equipment (net)
$92,792
$62,483
-33%
Other Assets
-
-
-
Total Assets
$5,980,953
$5,767,836
-4%
Liabilities
2024
2025
Change
Payables & Accruals
$333,395
$423,454
+27%
Grants Payable
$1,104,773
$536,699
-51%
Deferred Revenue
$60,000
$260,000
+333%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$1,498,168
$1,220,153
-19%
Net assets
2024
2025
Change
Restricted Net Assets
$1,018,631
$2,103,526
+107%
Unrestricted Net Assets
$3,464,154
$2,444,157
-29%
Net assets
2024
2025
Change
Net assets
+$4,482,785
+$4,547,683
+1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)